Zimmer Biomet Hl Rg
ZBH
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
09/02/2025 - 22:15:00
105.01
-1.09 ( -1.03% )
More information
Analysis by TheScreener
02.09.2025
Evaluation Slightly positive  
Interest Strong  
Sensibility Low  
Analysis date: 02.09.2025
Global Evaluation
  Slightly positive
The stock is classified in the slightly positive zone since 19.08.2025.
Interest
  Strong
Three stars since 19.08.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 08.07.2025 at a price of 93.47.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 08.08.2025.
4wk Rel Perf
  13.03%
 
The four-week dividend-adjusted overperformance versus SP500 is 13.03%.
Sensibility
  Low
The stock has been on the low-sensitivity level since 19.08.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.26%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.49%.
Mkt Cap in $bn
  21.02
With a market capitalization >$8bn, ZIMMER BIOMET is considered a large-cap stock.
G/PE Ratio
  0.85
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  11.11
The estimated PE is for the year 2027.
LT Growth
  8.47%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  22
Over the last seven weeks, an average of 22 analysts provided earnings per share estimates.
Dividend Yield
  0.94%
The twelve month estimated dividend yield represents 10.39% of earnings forecasts.
Beta
  44
For 1% of index variation, the stock varies on average by 0.44%.
Correlation
  0.32
Stock movements are strongly independent of index variations.
Value at Risk
  11.53
The value at risk is estimated at USD 11.53. The risk is therefore 10.98%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  24.07.2002